RecruitingNCT04011982

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors

Sponsor

Centre Leon Berard

Enrollment

300 participants

Start Date

Sep 1, 2020

Study Type

OBSERVATIONAL

Conditions

Exocrine Pancreatic Cancer

Summary

PATAKESS is a monocentric non interventional cohort study (prospective (alive patients) and retrospective (dead patients with biological material from surgery and/or biopsies already collected)). PATAKESS consists of clinical and biological analyses of exocrine pancreatic tumors. Data are derived from tumor samples taken for routine health care purposes in patients managed at Centre Léon Bérard (Lyon-France) since January 2010. The main objective is to determine correlation between biological and clinical characterizations of patients suffering from exocrine pancreatic tumor.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a detailed database of clinical and biological information from patients who have had surgery for pancreatic cancer (exocrine pancreatic adenocarcinoma) at a cancer center in France. The goal is to identify patterns that may lead to better treatments and outcomes. **You may be eligible if...** - You are 18 or older - You had surgery for exocrine pancreatic adenocarcinoma at Centre Léon Bérard since January 2010 - Your diagnosis was confirmed by pathology examination of the surgical specimen **You may NOT be eligible if...** - There are no formal exclusion criteria for this observational study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Centre Léon Bérard

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04011982

Related Trials

High Dose Omeprazole in Patients With Pancreatic Cancer

NCT049309911 location